SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-314121
Filing Date
2018-10-31
Accepted
2018-10-31 17:29:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A AMENDMENT NO. 2 d576002ds3a.htm S-3/A 175803
2 EX-5.1 d576002dex51.htm EX-5.1 8445
3 EX-23.1 d576002dex231.htm EX-23.1 1700
4 GRAPHIC g576002g0725075924972.jpg GRAPHIC 5156
5 GRAPHIC g576002g0725080823339.jpg GRAPHIC 2213
  Complete submission text file 0001193125-18-314121.txt   197602
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3/A | Act: 33 | File No.: 333-226341 | Film No.: 181151206
SIC: 3826 Laboratory Analytical Instruments